{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11092574", "DateCompleted": {"Year": "2001", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0022-3573", "JournalIssue": {"Volume": "52", "Issue": "10", "PubDate": {"Year": "2000", "Month": "Oct"}}, "Title": "The Journal of pharmacy and pharmacology", "ISOAbbreviation": "J Pharm Pharmacol"}, "ArticleTitle": "Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice.", "Pagination": {"StartPage": "1287", "EndPage": "1295", "MedlinePgn": "1287-95"}, "Abstract": {"AbstractText": ["Stilbene glucosides are naturally occurring phytoalexins, found in a variety of medicinal plants. Among the stilbene derivatives, resveratrol 3-O-D-glucoside (piceid) is found in grapes and wine. We studied the effects of stilbene glucosides isolated from medicinal plants and grapes on tumour growth and lung metastasis in mice bearing highly metastatic Lewis lung carcinoma (LLC) tumours. We also studied the inhibitory effects of stilbene glucosides on differentiation of human umbilical vein endothelial cells (HUVECs) to form a capillary network. Tumour growth in the right hind paw and lung metastasis were inhibited by oral administration of the stilbene glucosides, piceid and 2,3,5,4'-tetrahydroxystilbene-2-O-D-glucoside for 33 consecutive days, in LLC-bearing mice. As the number of CD8+ and NK1.1+ T cells in the spleen was not affected, the inhibitory effects of these stilbene glucosides on tumour growth and lung metastasis could not be explained by natural killer or cytotoxic T lymphocyte activation. Piceid inhibited the DNA synthesis in LLC cells at a concentration of 1000 microM, but not at lower concentrations (10-100 microM). 2,3,5,4'-Tetra-hydroxystilbene-2-O-D-glucoside also inhibited DNA synthesis in LLC cells (IC50 81 microM). In addition, both stilbene glucosides inhibited the formation of capillary-like tube networks (angiogenesis) of HUVECs at concentrations of 100 to 1000 microM. We suggest that the antitumour and antimetastatic activity of the stilbene glucosides, piceid and 2,3,5,4'-tetrahydroxystilbene-2-O-D-glucoside, might be due to the inhibition of DNA synthesis in LLC cells and angiogenesis of HUVECs."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Second Department of Medical Biochemistry, School of Medicine, Ehime University, Onsen-gun, Japan. yokim@m.chime-u.ac.jp"}], "Identifier": [], "LastName": "Kimura", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Okuda", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Pharmacol", "NlmUniqueID": "0376363", "ISSNLinking": "0022-3573"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "133186-49-9", "NameOfSubstance": "2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}, {"RegistryNumber": "EC 1.17.4.-", "NameOfSubstance": "Ribonucleotide Reductases"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy", "secondary"], "DescriptorName": "Carcinoma, Lewis Lung"}, {"QualifierName": [], "DescriptorName": "Cattle"}, {"QualifierName": ["biosynthesis", "drug effects"], "DescriptorName": "DNA"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug effects"], "DescriptorName": "Organ Size"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Resveratrol"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Ribonucleotide Reductases"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Spleen"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Stilbenes"}, {"QualifierName": [], "DescriptorName": "Swine"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Thymus Gland"}, {"QualifierName": [], "DescriptorName": "Umbilical Veins"}, {"QualifierName": ["analysis"], "DescriptorName": "Wine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "11", "Day": "25", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "6", "Day": "2", "Hour": "10", "Minute": "1"}, {"Year": "2000", "Month": "11", "Day": "25", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11092574", "10.1211/0022357001777270"]}}], "PubmedBookArticle": []}